scispace - formally typeset
G

Georg Juckel

Researcher at Ruhr University Bochum

Publications -  551
Citations -  14509

Georg Juckel is an academic researcher from Ruhr University Bochum. The author has contributed to research in topics: Medicine & Schizophrenia. The author has an hindex of 56, co-authored 479 publications receiving 12633 citations. Previous affiliations of Georg Juckel include Charité.

Papers
More filters
Journal ArticleDOI

Switching schizophrenia patients from typical neuroleptics to olanzapine: effects on BOLD response during attention and working memory.

TL;DR: It was showed that switching patients from conventional neuroleptics to olanzapine did not significantly alter the frontal or parietal BOLD response during working memory task, however, medication status had influences on the activation during attentional task (0-back), emphasizing the importance of baseline selection in pharmacological fMRI studies.
Journal ArticleDOI

Mental state decoding and mental state reasoning in recently detoxified alcohol-dependent individuals.

TL;DR: Behavioural measures suggest pronounced impairments of mental state decoding and mental state reasoning in association with alcohol dependence and ought to be incorporated into current treatment strategies.
Journal ArticleDOI

Neuroanatomical correlates of suicide in psychosis: the possible role of von Economo neurons.

TL;DR: The density of VENs was significantly greater in the ACC of suicide victims with psychotic disorders compared with psychotic individuals who died from other causes, and may support the assumption that VEN have a special role in emotion processing and self-evaluation, including negative self-appraisal.
Journal ArticleDOI

Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation.

TL;DR: This study showed for the first time that the partial dopamine antagonist aripiprazole increases BOLD-signal during a WM task in the cognitive part of the ACC in schizophrenia patients, which may reflect its beneficial effect on cognitive deficits.